SARS-CoV-2 IgG/IgM Rapid Qualitative Test Kit

Manufactured by Xiamen Biotime Biotechnology Co., Ltd., China - www.biotime.cn/En_ 

Related Scientific Literature

• Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
• Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays
• Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
• Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
• Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
• Clinically practiced and commercially viable nanobio engineered analytical methods for COVID-19 diagnosis
• Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements